Article Information
History
- February 10, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ikram Omar Osman1,
- Cléa Melenotte1,
- Philippe Brouqui1,
- Matthieu Million1,
- Jean-Christophe Lagier1,
- Philippe Parola2,
- Andréas Stein1,
- Bernard La Scola1,
- Line Meddeb1,
- Jean-Louis Mege1,
- Didier Raoult1 and
- Christian A. DEvaux1,3,*
- 1Aix-Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France
- 2Aix-Marseille Univ, IRD, APHM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France
- 3CNRS, Marseille, France
- ↵*Corresponding author :
Christian Devaux, PhD, IHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13385 Marseille, France, Phone: (+33) 4 13 73 20 51, Fax : (+33) 4 13 73 20 52, E-mail: christian.devaux{at}mediterranee-infection.com
Posted February 10, 2021.
Expression of ACE2 receptor, soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin (1-7), is modulated in COVID-19 patients
